OTC Drug Monograph Review Process

Click any of the following boxes

Final Monograph/Amendment Published in the FR and CFR Return to OTC for Revisions/Further Discussion Concurrence Final Monograph or Final Amendment Prepared Public Comment Proposed Monograph/Amendment Published in FR Meeting Between OTC Division and Submitter Preparation of Feedback Letter Review by CDER Review by Consultants OTC Advisory Committee Meeting Data Submitted to the Agency Concurrence